Popular weight-loss drugs are meant to be lifelong medications treating a disease, not lifestyle fixes.

The GLP-1 medication is now available via injection and pill.

Anything that helps Americans lose weight, reduces treatment barriers and makes care more affordable should be welcomed. But ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

Does the new Wegovy pill work as well as Wegovy injections for weight loss? How else does it compare? Learn what the experts ...

In December, Novo Nordisk announced that the Food and Drug Administration had approved its once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the United States. It remains the only ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.

Compounded semaglutide is a medication that’s custom-made by a compounding pharmacy. It contains the active ingredient semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist.

The pill version of Wegovy could be a game-changer for GLP-1 medications. Unlike the injectable form, it doesn't require ...

British Columbians could soon have access to cheaper versions of injectable diabetes and obesity drugs.

GLP-1 agonist injections, although originally developed to treat type 2 diabetes, have changed how we approach obesity.1 The two main types now in use—semaglutide (Wegovy), produced by Novo Nordisk, ...

Add Yahoo as a preferred source to see more of our stories on Google. Patients are now able to get Novo Nordisk's Wegovy pill for weight loss. - Novo Nordisk Americans seeking to lose weight now have ...